In agreement with the finding that TGF-β1 promotes glioma cell migration and braininvasion, treatment of glioma cells with micromolar doses of Δ2-troglitazoneeffectively blocks their migrative properties (Figure 2). This evidence concerns the gene TGFB1 and glioma.